Little Journey Transforms Paediatric Care with £6m Funding

Little Journey, a healthtech company specializing in pediatric care, has raised £6 million in a Series A funding round. Investors in this round include Mercia Ventures, Northern Powerhouse Investment Fund, Par Equity, Octopus Ventures, Calm/Storm Ventures, and various angel investors. The company plans to use the funds to further expand its global operations, targeting the US healthcare market with an aim to improve pediatric clinical trials and support systems. Little Journey also anticipates product enhancements that will improve data collection and interoperability, making healthcare more patient-centric and data-focused. The funding will bolster the company's infrastructure for scaling globally while ensuring robust security measures. Founded in 2018 by Chris Evans and Sophie Copley, Little Journey has already established a significant global presence, being used in over 100 hospitals across 11 countries. The company also collaborates with pharmaceutical companies to improve pediatric clinical trials, helping reduce barriers to trial participation and accelerating the development of children's medicines. The funding round is further supported by a substantial grant from LEGO Foundation and SBRI Healthcare to enhance app accessibility for children with disabilities and engage neurodivergent children.